THEOPHYLLINE solution United States - English - NLM (National Library of Medicine)

theophylline solution

chartwell rx, llc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline oral solution is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

teva pharmaceuticals, inc. - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

chartwell rx, llc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

amneal pharmaceuticals ny llc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

avkare - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

leading pharma, llc - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE solution United States - English - NLM (National Library of Medicine)

theophylline solution

bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline oral solution is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline oral solution is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEO-24- theophylline anhydrous capsule, extended release United States - English - NLM (National Library of Medicine)

theo-24- theophylline anhydrous capsule, extended release

endo pharmaceuticals, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theo-24 is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

UNIPHYL- theophylline anhydrous tablet United States - English - NLM (National Library of Medicine)

uniphyl- theophylline anhydrous tablet

purdue pharmaceutical products lp - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 400 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. uniphyl® is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

ELIXOPHYLLIN- theophylline anhydrous liquid United States - English - NLM (National Library of Medicine)

elixophyllin- theophylline anhydrous liquid

nostrum laboratories, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir (theophylline oral solution, usp) is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.